Despite the topline growth, J&J’s net earnings fell 37.5% to $2.6 billion, down from $4.3 billion in Q3 2023. Johnson & ...

The bulk fund was created in 2019 to provide free naloxone to organizations like the Harm Reduction Action Center.

Lundbeck’s acquisition of Longboard Pharmaceuticals is meant to bolster its neuro-rare disease franchise, the drugmaker ...

NEW YORK: Sloane & Company has appointed Leslie Wheeler as a managing director in the firm’s healthcare practice.

Sociologist Elena Portacolone was taken aback. Many of the older adults in San Francisco she visited at home for a research project were confused when she came to the door. They’d forgotten the ...

The branding campaign from Mira, a San Francisco-based femtech, raised awareness through a combination of research, human connection and hope.

The second annual MM+M/Publicis Health Pharma Marketing Transformation Survey shows innovation is beginning to take hold, although pharma still has a long way to go to digitally enable the marketing ...

Resulting in a 92% reduction in potential adspend losses, US advertisers were saved billions of ad dollars courtesy of ...

Nearly 4 in 10 women under 30 surveyed in September and early October told pollsters that abortion is the most important issue to their vote.

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

Thrivers, survivors and “pinkwashing” dominate October campaigns. What’s missing is education about the disease, those being ...

Recent research suggests that the FDA’s black box warning for antidepressants may have had the opposite effect it intended.